RankAlpha logo
Back to Rankings

CLRB

Cellectar BiosciencesA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
CLRB vs peer average
95/100
CLRB vs. peer average (A vs. D)
Grade spread
A 1 · C 1 · D 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

TVRD is the first available peer comparator.

Same-sector, similarly sized biotech candidate; useful for event-volatility comparison but not a direct radiopharmaceutical operating peer.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerTVRDTvardi Therapeutics
CLRB
Cellectar Biosciences
TVRD
Tvardi Therapeutics
Grade
A
F
Momentum
69
7
Value
58
41
Sentiment
74
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs TVRD

CLRB / TVRD
Grade Position
Above peers
CLRB vs. peer average (A vs. D)
95/100
Momentum
69
CLRB
Value
58
CLRB
Sentiment
74
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CLRB
1
TVRD
TVRD
F
20/100
+4
2
BRNS
BRNS
D
40/100
+3
3
ACTU
ACTU
F
20/100
+4
4
CNSY
Cerenome Inc Common
F
20/100
+4
5
QNTM
Quantum Biopharma Ltd Subordinate Voting Shares Class B Common
C
60/100
+2
TVRD is the first peer returned for this comparison set.